عنوان
پدید آورنده
موضوع
رده
RS57.S8 2005
RS57
.
S8
2005
کتابخانه
محل استقرار
INTERNATIONAL STANDARD BOOK NUMBER
(Number (ISBN
142005645X
(Number (ISBN
9781420056457
TITLE AND STATEMENT OF RESPONSIBILITY
Title Proper
Statistics in the Pharmaceutical Industry
General Material Designation
[Book]
EDITION STATEMENT
Edition Statement
3rd ed.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Boca Raton :
Name of Publisher, Distributor, etc.
Chapman and Hall/CRC,
Date of Publication, Distribution, etc.
2018.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (497 pages)
SERIES
Series Title
Chapman and Hall/CRC Biostatistics Ser. ;
Volume Designation
v. Vol. 15
CONTENTS NOTE
Text of Note
Cover; Half Title; Title Page; Copyright Page; Dedication; Series Introduction; Preface to the Third Edition; Preface to the Second Edition; Preface to the First Edition; Contributors; Table of Contents; Chapter 1 Introduction to the Evolution of Pharmaceutical Products; Chapter 2 Statistical Review and Evaluation of Animal Carcinogenicity Studies of Pharmaceuticals; Chapter 3 The FDA and the IND/NDA Statistical Review Process; Chapter 4 Clinical Trial Designs; Chapter 5 Selecting Patients for a Clinical Trial; Chapter 6 Statistical Aspects of Cancer Clinical Trials
Text of Note
Chapter 15 A Regulatory Perspective on Data Monitoring and Interim AnalysisChapter 16 Complex Adaptive Systems, Human Health, and Drug Response: Statistical Challenges in Pharmacogenomics; Chapter 17 Phase IV Postmarketing Studies; Chapter 18 The Role of Contract Research Organizations in Clinical Research in the Pharmaceutical Industry; Chapter 19 Global Harmonization of Drug Development -- A Clinical Statistics Perspective; Chapter 20 Bridging Strategies in Global Drug Development; Chapter 21 Design and Analysis Strategies for Clinical Pharmacokinetic Trials
Text of Note
Chapter 22 Stability Studies of PharmaceuticalsChapter 23 When and How to Do Multiple Comparisons; Chapter 24 Reference Intervals (Ranges): Distribution-Free Methods vs. Normal Theory; Index
Text of Note
Chapter 7 Recent Statistical Issues and Developments in Cancer Clinical TrialsChapter 8 Design and Analysis of Testosterone Replacement Therapy Trials; Chapter 9 Clinical Trials of Analgesic Drugs; Chapter 10 Statistical Issues in HIV/AIDS Research; Chapter 11 The Wonders of Placebo; Chapter 12 Active-Controlled Noninferiority/Equivalence Trials: Methods and Practice; Chapter 13 Interim Analysis and Bias in Clinical Trials: The Adaptive Design Perspective; Chapter 14 Interim Analysis and Adaptive Design in Clinical Trials
0
8
8
8
OTHER EDITION IN ANOTHER MEDIUM
Title
Statistics in the Pharmaceutical Industry.
International Standard Book Number
9780824754693
DEWEY DECIMAL CLASSIFICATION
Number
615/
.
1901/072
LIBRARY OF CONGRESS CLASSIFICATION
Class number
RS57
.
S8
2005
PERSONAL NAME - PRIMARY RESPONSIBILITY
Buncher, C. Ralph.
PERSONAL NAME - ALTERNATIVE RESPONSIBILITY
Tsay, Jia-Yeong.
ORIGINATING SOURCE
Date of Transaction
20200822182220.0
Cataloguing Rules (Descriptive Conventions))
pn
ELECTRONIC LOCATION AND ACCESS
Electronic name
مطالعه متن کتاب [Book]
Y
